Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

Figure 1 A stepwise approach: Abnormal liver test in inflammatory bowel disease. ¹If the study is negative consider liver biopsy. Created with Biorender. IBD: Inflammatory bowel disease; ALF: Acute liver failure; NASH: Nonalcoholic steatohepatitis; HBV: Hepatitis B virus; PSC: Primary sclerosing cholangitis; PBC: Primary biliar cholangitis; DILI: Drug induced liver injury.

Figure 2 Non-alcoholic fatty liver disease risk factor in inflammatory bowel disease. Created with Biorender. IBD: Inflammatory bowel disease; NAFL: Nonalcoholic fatty liver; NASH: Nonalcoholic steatohepatitis; BMI: Body mass index; DM2: Diabetes mellitus 2; IR: Insulin resistance; DILI: Drug induced liver injury.

Figure 3 Others hepatic manifestations. Created with Biorender. DM2: Diabetes mellitus 2; IBD: Inflammatory bowel disease; CD: Crohn’s disease; UC: Ulcerative colitis.